Matches in Nanopublications for { ?s ?p "[Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP301049.RAThsjlB_uiT9su3Enoky61WTDbCf6RzsjI-HytfE4qL4130_assertion description "[Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301049.RAThsjlB_uiT9su3Enoky61WTDbCf6RzsjI-HytfE4qL4130_provenance.
- NP288319.RABPTe5948o_Eo0MTWmu0ChVFzOrih0foEiP-IjNXuRcY130_assertion description "[Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288319.RABPTe5948o_Eo0MTWmu0ChVFzOrih0foEiP-IjNXuRcY130_provenance.
- NP1107629.RARfLpCE43hD0tQAcWWPK17NYz6bJyTJQfrOagoP5kuOo130_assertion description "[Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1107629.RARfLpCE43hD0tQAcWWPK17NYz6bJyTJQfrOagoP5kuOo130_provenance.
- NP1107630.RAqish7PPe5J1634e5UKtYOaiRU5oSUpZgutWVsa8Mhm0130_assertion description "[Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1107630.RAqish7PPe5J1634e5UKtYOaiRU5oSUpZgutWVsa8Mhm0130_provenance.
- NP300819.RAzzQ6Fmh6xR7Pko3FVV8wuo_Aq7iAr5X7yG5Iee5xYwg130_assertion description "[Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300819.RAzzQ6Fmh6xR7Pko3FVV8wuo_Aq7iAr5X7yG5Iee5xYwg130_provenance.
- NP288276.RAGi70YWSFC16b4mr8OnWl7qpswrnNJNPtZcnYJvzvYEw130_assertion description "[Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288276.RAGi70YWSFC16b4mr8OnWl7qpswrnNJNPtZcnYJvzvYEw130_provenance.
- NP1107627.RAF0bnChrX6TdLvGT2RoJuK8hTA7v_t4iZuAZwFLr9UfI130_assertion description "[Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1107627.RAF0bnChrX6TdLvGT2RoJuK8hTA7v_t4iZuAZwFLr9UfI130_provenance.
- NP1107628.RAF-0hn4KrdIe9UbEe2_3CGF0HY5jXfJKcWOPJMNRAToQ130_assertion description "[Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1107628.RAF-0hn4KrdIe9UbEe2_3CGF0HY5jXfJKcWOPJMNRAToQ130_provenance.